News Website

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 Los Angeles

More people are living 5 years after cancer diagnosis, new ACS data shows ABC7 Los Angeles

Published: Jan. 13, 2026, 5:02 p.m.

Read Full Article

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC30 Fresno

More people are living 5 years after cancer diagnosis, new ACS data shows ABC30 Fresno

Published: Jan. 13, 2026, 5:02 p.m.

Read Full Article

ASCO 2025: key highlights in endometrial cancer - springermedicine.com

ASCO 2025: key highlights in endometrial cancer springermedicine.com

Published: Jan. 13, 2026, 5:23 a.m.

Read Full Article

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer The ASCO Post

Published: Jan. 12, 2026, 6:10 p.m.

Read Full Article

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment SurvivorNet

Published: Jan. 11, 2026, 6:06 p.m.

Read Full Article

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology

Published: Jan. 11, 2026, 4:14 p.m.

Read Full Article

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now - SurvivorNet

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now SurvivorNet

Published: Jan. 10, 2026, 5:07 p.m.

Read Full Article

Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan - Defense World

Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan Defense World

Published: Jan. 10, 2026, 6:12 a.m.

Read Full Article

Endometrial Cancer: Evaluating Platinum Re-Challenge Strategies Through the ECHO-EU Lens - OncLive

Endometrial Cancer: Evaluating Platinum Re-Challenge Strategies Through the ECHO-EU Lens OncLive

Published: Jan. 9, 2026, 8:25 p.m.

Read Full Article

Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data - Investing.com UK

Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data Investing.com UK

Published: Jan. 9, 2026, 2:25 p.m.

Read Full Article

Latest Articles

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC7 Los Angeles

More people are living 5 years after cancer diagnosis, new ACS data shows - ABC30 Fresno

ASCO 2025: key highlights in endometrial cancer - springermedicine.com

Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer - The ASCO Post

‘She’s Literally Busy Fighting Cancer:’ Howard Stern’s Sidekick Robin Quivers, 73, Expected to Continue On Radio Show But Will Focus On Cancer Treatment - SurvivorNet

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

‘Guiding Light’ Soap Opera Actress Beth Chamberlin, 62, Says She Received a Hysterectomy After Endometrial Cancer Diagnosis – ‘I Didn’t Tell Anyone, Not Even My Family’ Until Now - SurvivorNet

Acrivon Therapeutics Spotlights ACR368 Endometrial Cancer Data, Adds Serous Arm 3 and FDA Phase 3 Plan - Defense World

Endometrial Cancer: Evaluating Platinum Re-Challenge Strategies Through the ECHO-EU Lens - OncLive

Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data - Investing.com UK

Subscribe to Our Newsletter